Zituvimet

Active Ingredient(s): Sitagliptin + Metformin Hydrochloride
FDA Approved: * November 3, 2023
Pharm Company: * ZYDUS WORLDWIDE DMCC
Category: Diabetes

Sitagliptin/metformin, sold under the brand name Janumet among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes.[6] It may be used in those whose blood sugar is not controlled with metformin and a sulfonylurea.[6][7] It is taken by mouth.[6] Common side effects include diarrhea, headache, and upper respiratory tract infections.[1] Serious side effects may include lactic ac... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zituvimet Oral Tablet, Film Coated
NDC: 70710-1786
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Zituvimet Oral Tablet, Film Coated
NDC: 70710-1787
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Zituvimet Oral Tablet, Film Coated
NDC: 70771-1859
Labeler:
Zydus Lifesciences Limited
Zituvimet Oral Tablet, Film Coated
NDC: 70771-1860
Labeler:
Zydus Lifesciences Limited

Related Brands

Drugs with the same active ingredients